Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 85 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Bob A. L.

United States

USD 85 /hr

A scientist with extensive experience in immunology, inflammation, pharmacology, and toxicology.

Profile Summary

I am experienced in designing in-vitro and in-vivo proof-of-concept experiments, execution, data analysis, data interpretation, and generation of manuscripts for publication. Experience managing and developing an innovative translational study to accurately predict human pharmacokinetics and pharmacodynamics. Robust analytical, drug discovery and problem-solving, cross-training, and mentoring colleagues.

Subject Matter Expertise

• ★ Experimental Protocols
• ☆ Zoology
• ☆ Animal Science
• ☆ Drug Development
• ☆ Medical Sciences

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Technical Writing

Research Market Research, Feasibility Study, Gap Analysis, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Big Data Analytics, Data Processing

Product Development Product Evaluation

Work Experience

Harvard University Wyss Institute for Biologically Inspired Engineering

May 2021 - Present

Principal Scientist Consulting

SciBioix Consulting

January 2018 - Present

Director of In-vitro Science

Iontox, LLC

February 2020 - May 2020

Manager

SciKon Innovation (United States)

October 2018 - January 2020

Research Associate

The University of North Carolina at Chapel Hill

December 2016 - July 2018

Postdoctoral Research Associate

The University of North Carolina at Chapel Hill

October 2011 - December 2016

Education

Ph.D., Biomedical & Pharmacology Sciences

Universite Catholique de Louvain

September 2007 - September 2011

PhD, Biomedical & Pharmaceutical Sciences (The Louvain Centre for Toxicology and Applied Pharmacology)

Université Catholique de Louvain

September 2007 - September 2011

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2021). Chronic E-Cigarette Exposure Alters Human Alveolar Macrophage Morphology and Gene Expression . Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

(2017). [XBP1 and inflammation in cystic fibrosis alveolar macrophages] . Medecine sciences : M/S.

(2017). Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation . International journal of molecular sciences.

(2015). X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages . American journal of respiratory and critical care medicine.

(2012). Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy . Clinical biochemistry.

(2012). Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice . Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

(2009). Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice . American journal of respiratory and critical care medicine.

(2007). Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis . American journal of respiratory and critical care medicine.